Showing results (81-90 of 186) with videos related to
Sort By:
Pageof 19
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 3, 2010
A formal risk-benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practiceDavid L Veenstra, Joshua A Roth, Louis P Garrison, et al.Journal of Medical Economics|December 15, 2021
Assessing health-related quality-of-life in patients with symptomatic obstructive hypertrophic cardiomyopathy: EQ-5D-based utilities in the EXPLORER-HCM trialJipan Xie, Yan Wang, Yaping Xu, et al.Journal of Evaluation in Clinical Practice|October 21, 2016
A proposed approach for quantitative benefit-risk assessment in diagnostic radiology guideline development: the American College of Radiology Appropriateness Criteria ExampleMaria Agapova, Brian B Bresnahan, Mitchell Higashi, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 10, 2024
Does Real Option Value Influence Oncologists' Treatment Recommendations? A Survey of US OncologistsMeng Li, Zizi Elsisi, William Wong, et al.Academic Radiology|June 28, 2011
Innovation in diagnostic imaging services: assessing the potential for value-based reimbursementLouis P Garrison, Brian W Bresnahan, Mitchell K Higashi, et al.Nutrition (Burbank, Los Angeles County, Calif.)|July 24, 2017
Effects of arginine-based immunonutrition on inpatient total costs and hospitalization outcomes for patients undergoing colorectal surgerySouvik Banerjee, Louis P Garrison, Aurelie Danel, et al.Journal of Managed Care & Specialty Pharmacy|September 26, 2017
Paying for Cures: How Can We Afford It? Managed Care Pharmacy Stakeholder Perceptions of Policy Options to Address Affordability of Prescription DrugsKai Yeung, Kangho Suh, Anirban Basu, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 20, 2010
Preference values associated with stage III colon cancer and adjuvant chemotherapyJennie H Best, Louis P Garrison, William Hollingworth, et al.Academic Radiology|August 10, 2014
Applying quantitative benefit-risk analysis to aid regulatory decision making in diagnostic imaging: methods, challenges, and opportunitiesMaria Agapova, Emily Beth Devine, Brian W Bresnahan, et al.Plos One|April 8, 2015
The short-term cost-effectiveness of once-daily liraglutide versus once-weekly exenatide for the treatment of type 2 diabetes mellitus in the United StatesBruce Wang, Joshua A Roth, Hiep Nguyen, et al.Pageof 19